文献速递眼底病与葡萄膜炎白内障与屈光手术青光眼

长期眼内应用眼科黏弹剂的系统综述:安全性概况

Safety profile of long-term intraocular ophthalmic viscoelastic devices: a systematic review.
PubMed 文献 · Br J Ophthalmol · 2026-07-22

该系统综述通过检索Medline和Embase数据库,共纳入38项研究,评估长期眼内应用眼科黏弹剂(OVD)的安全性。由于研究间不适合直接头对头比较,仅作描述性分析。结果显示,透明质酸(HA)基OVD研究最充分,短期和长期体内外及动物研究均显示良好生物物理特性和极少不良反应;羟丙基甲基纤维素(HPMC)和硫酸软骨素(CS)基产品尽管常用,但长期安全性数据有限。

要点

  • HA基OVD长期眼内应用安全性证据最充分,不良反应极少。
  • HPMC和CS基OVD的长期安全性数据有限,存在文献空白。
  • 纳入研究异质性大,无法进行直接头对头比较。

核心结论

  • HA基OVD具有高度良好的生物物理特性,短期和长期体内外及动物研究中不良反应极少。
  • HPMC和CS基产品尽管流行,但长期安全性数据有限,代表文献空白。

研究设计与样本

  • 系统综述,检索Medline和Embase数据库(通过OVID),从建库至检索日,无语言限制,关键词为「viscoelastics」和「intraocular」。
  • 最终纳入38项研究,因研究间不适合直接头对头比较,采用描述性分析。

主要发现

  • 长期眼内应用OVD的高质量安全性证据匮乏。
  • HA基OVD是研究最充分的,有多个长期眼内应用研究。
  • HPMC和CS基产品的长期安全性数据有限。

临床怎么用

  • 临床选择长期眼内应用的OVD时,HA基产品拥有最充分的安全性证据支持。
  • 在玻璃体视网膜手术和慢性低眼压等新应用领域,使用HPMC或CS基产品需谨慎,因长期安全性证据不足。

局限性

  • 纳入研究不适合直接头对头比较,仅能进行描述性分析。
  • 长期眼内应用OVD的高质量证据整体匮乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Since first being introduced over 50 years ago, ophthalmic viscoelastic devices (OVDs) have revolutionised the fields of cataract, cornea and glaucoma surgery, with extensive published anterior segment safety data available. More recently, these devices have also gained popularity in posterior segment surgery, with particular focus on their potential use as long-lasting, non-toxic, biocompatible and biodegradable vitreous substitutes. The most commercially available products are based on hydrophilic polymers such as hyaluronic acid (HA), hydroxypropylmethylcellulose (HPMC) and chondroitin sulfate (CS). This remains a novel area of research, with very few studies examining their long-term safety profile. METHODS: We conducted a systematic review on Medline and Embase via OVID, using key words "viscoelastics" and "intraocular". Both databases were searched from inception date, with no language limitations. RESULTS: There is a paucity of high-quality evidence addressing the long-term safety of OVDs in the eye. A total of 38 studies were included for final review. These studies were unsuitable for any direct head-to-head comparisons; therefore, a descriptive analysis is presented. CONCLUSIONS: By far, HA-based OVDs have been the most well described, with several long-term intraocular applications. They display highly favourable biophysical properties with minimal adverse reactions in short and long-term in vivo, in vitro and animal studies. There is limited safety data on HPMC and CS-based products, despite their popularity. This represents a gap in the literature and invites the need for high-quality evidence to support their continued use, particularly in the realms of vitreoretinal surgery and chronic hypotony.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Khalil R, Shah D, Sutaria A, et al. Safety profile of long-term intraocular ophthalmic viscoelastic devices: a systematic review. Br J Ophthalmol. 2026. PMID: 41558833. doi:10.1136/bjo-2025-327856

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。